Leshchenko I V, Kuznetsova E I
Ter Arkh. 1997;69(12):52-4.
68 patients with bronchial asthma (BA) were followed up for 2 years. 11 of them suffered from BA stage III (group 1), 27 patients had BA stage IV (group 2). All the patients were administered ingacort as a basic medicine in daily dose 1000-2000 micrograms/day. Before ingacort treatment, patients of group 2 received prednisolone in daily dose 5-40 mg for 2-20 years. As a result of the treatment with ingacort group 1 and group 2 patients improved to stage II and III, respectively. The cost of the treatment was reduced 3.6-fold.
